Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook

Illumina Inc. shares sank 20% after hours Thursday after the gene-sequencing company swung to a loss in the second quarter, fell short of revenue expectations and revised its full-year outlook downwar...

Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales

Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...